JP2002513733A - 医薬組成物 - Google Patents

医薬組成物

Info

Publication number
JP2002513733A
JP2002513733A JP2000546727A JP2000546727A JP2002513733A JP 2002513733 A JP2002513733 A JP 2002513733A JP 2000546727 A JP2000546727 A JP 2000546727A JP 2000546727 A JP2000546727 A JP 2000546727A JP 2002513733 A JP2002513733 A JP 2002513733A
Authority
JP
Japan
Prior art keywords
vitamin
composition
compound
tumor
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000546727A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002513733A5 (enExample
Inventor
モリス，デービッド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unisearch Ltd
Original Assignee
Unisearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unisearch Ltd filed Critical Unisearch Ltd
Publication of JP2002513733A publication Critical patent/JP2002513733A/ja
Publication of JP2002513733A5 publication Critical patent/JP2002513733A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2000546727A 1998-05-04 1999-05-04 医薬組成物 Pending JP2002513733A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP3328A AUPP332898A0 (en) 1998-05-04 1998-05-04 Pharmaceutical composition
AU3328 1998-05-04
PCT/AU1999/000323 WO1999056697A2 (en) 1998-05-04 1999-05-04 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
JP2002513733A true JP2002513733A (ja) 2002-05-14
JP2002513733A5 JP2002513733A5 (enExample) 2006-03-30

Family

ID=3807582

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000546727A Pending JP2002513733A (ja) 1998-05-04 1999-05-04 医薬組成物

Country Status (9)

Country Link
US (1) US6664246B2 (enExample)
EP (1) EP1124557A4 (enExample)
JP (1) JP2002513733A (enExample)
KR (1) KR20010052305A (enExample)
CN (1) CN1204893C (enExample)
AU (1) AUPP332898A0 (enExample)
HK (1) HK1044117B (enExample)
WO (1) WO1999056697A2 (enExample)
ZA (1) ZA200006953B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087350A (en) 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
US7129230B2 (en) * 2001-03-12 2006-10-31 Nestec S.A. Method and product for treating cancer in pets
US20050038022A1 (en) * 2001-03-26 2005-02-17 Unisearch Limited Method for treatment of cancer and compositions for use therein
AUPR644301A0 (en) * 2001-07-17 2001-08-09 Unisearch Limited Method and composition for treatment of cancer
US20050209551A1 (en) * 2004-03-18 2005-09-22 Takemoto Arnold C Detoxification and breast health preparations
CA2558202A1 (en) * 2006-09-14 2006-11-23 Reinhold W. Vieth Vitamin d compositions and method of administration to infants
ITMI20121041A1 (it) 2012-06-15 2013-12-16 Lga Biotecnologie S R L Chemioprevenzione del cancro del colon - retto
CN106109476A (zh) * 2016-06-13 2016-11-16 中山大学 骨化二醇作为吲哚胺2,3‑双加氧酶‑1抑制剂的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260067A (en) * 1988-11-16 1993-11-09 Xu Zheng Cytotropic heterogeneous molecular lipids (CHML) and process for preparing the same
US5798345A (en) * 1990-09-21 1998-08-25 Bone Care International, Inc. Method of inhibiting the hyperproliferation of malignant cells
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
EP0619305B1 (en) * 1993-02-05 1997-06-04 Teijin Limited Lactone compound and process of producing thereof
AUPO727097A0 (en) * 1997-06-10 1997-07-03 Unisearch Limited Method of treatment of hepatoma and pharmaceutical compositions for use therein
CN1090180C (zh) * 1997-06-25 2002-09-04 帝人株式会社 维生素d3衍生物及其用于炎性呼吸道疾病的治疗剂

Also Published As

Publication number Publication date
WO1999056697A2 (en) 1999-11-11
WO1999056697A3 (en) 2001-06-21
EP1124557A4 (en) 2002-08-07
CN1204893C (zh) 2005-06-08
EP1124557A2 (en) 2001-08-22
US20020128239A1 (en) 2002-09-12
KR20010052305A (ko) 2001-06-25
HK1044117A1 (en) 2002-10-11
CN1332629A (zh) 2002-01-23
HK1044117B (zh) 2005-10-21
US6664246B2 (en) 2003-12-16
ZA200006953B (en) 2002-03-28
AUPP332898A0 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
KR100382219B1 (ko) 간 종양 치료용 조성물
KR101926320B1 (ko) 전립선 암종의 치료를 위한 병용 요법
EP0910382A1 (en) Treatment of carcinomas using squalamine in combination with other anti-cancer agents
JP2001515864A (ja) 非天然ｆｐ選択的作用薬を使用した骨体積増加方法
Figg et al. A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone‐refractory prostate cancer
JP2002513733A (ja) 医薬組成物
Karavokiros et al. Flumazenil: a benzodiazepine antagonist
Ahlman et al. Management of disseminated midgut carcinoid tumours
JP2006514665A (ja) 慢性心不全および／または上昇したコレステロールレベルを処置するための方法
Morris et al. Hepatic intra-arterial injection of 1, 25-dihydroxyvitamin D3 in lipiodol: Pilot study in patients with hepatocellular carcinoma
US20040067952A1 (en) Method and composition for treatment of cancer
AU765846B2 (en) Pharmaceutical composition
Finlay et al. A phase one study of the hepatic arterial administration of 1, 25‐dihydroxyvitamin D3 for liver cancers
Keller et al. Growth inhibition of experimental non‐Hodgkin's lymphomas with the targeted cytotoxic somatostatin analogue AN‐238
EP1698332A1 (en) Oral modified release formulations containing 8-Prenylnaringenin for continuous estrogen support
JP2001515863A (ja) 骨体積増加方法
Oates et al. Pancreatic blood flow in the rat during enlargement, involution, and cholecystokinin treatment
Minuck Reactions to Drugs during Surgery and Anæsthesia
Chiang et al. Lung deposits of lipiodol in normal and cirrhotic rats
AU2002318983A1 (en) Mathod and composition for treatment of cancer
Van Veelen et al. 5 Oral high-dose medroxyprogesterone acetate (MPA) versus tamoxifen (TAM) in advanced breast cancer and cross-over effect
Priestman et al. 6 A randomised trial of aminoglutethimide (AG) versus medroxyprogesterone acetate (MPA) as second-line agents in advanced carcinoma of the breast
WO2003004036A1 (fr) Compositions medicinales pour le traitement de l'hyperfonction des glandes parathyroides secondaires et medicaments servant a traiter les complications cardiovasculaires liees au traitement de l'hyperfonction des glandes parathyroides secondaires
AU7631698A (en) Method of treatment of liver tumours and pharmaceutical compositions for use therein

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060208

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090915

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100302